Physician

Philip James Abraham, M.D.

According to 2025 Medicare claims, Philip Abraham, M.D. (NPI: 1548375629) practices pulmonary disease in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is SPRINGFIELD CLINIC, LLP (NPI: 1780638478; TIN: 370701328) and primary practice location at 62703-2403. Abraham is affiliated with the Springfield Clinic ACO, LLC (ACO ID: A2587), IRCCO (ACO ID: A2619), and SSM IL ACO, LLC (ACO ID: A4832), participating under the MSSP model.

Abraham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 829 traditional Medicare patients, billed 5,819 HCPCS/CPT codes, and received $405,624 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,406 prescription claims across 791 beneficiaries totaling $1,907,210 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,825 claims. Open Payments data shows 8 records totaling $119. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $198,908 to $405,624. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $388,737 to $1,907,210. For DME billing, reported payments rose steadily, from $192,803 to $214,030.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	596	4,181	$198,908
2016	654	4,680	$212,228
2017	775	5,344	$222,357
2018	761	5,285	$224,284
2019	778	4,600	$213,632
2020	804	4,371	$229,828
2021	887	4,516	$257,224
2022	832	4,998	$300,337
2023	853	6,635	$380,537
2024	829	5,819	$405,624

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	282	1,706	$388,737
2016	343	2,113	$501,268
2017	416	2,915	$726,042
2018	444	3,018	$836,875
2019	498	3,376	$1,065,906
2020	570	3,933	$1,373,971
2021	638	4,005	$1,493,988
2022	668	4,481	$1,671,868
2023	751	4,916	$1,880,896
2024	791	5,406	$1,907,210

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	827	2,957	$201,494
2016	932	3,497	$169,512
2017	1,139	4,195	$190,745
2018	1,333	4,502	$220,238
2019	1,479	4,757	$238,346
2020	1,523	4,631	$250,506
2021	1,470	4,703	$248,348
2022	1,343	4,116	$231,111
2023	1,416	3,932	$255,452
2024	1,363	3,825	$214,400

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	399	533	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	181	205	$62
94726	Test to determine lung volumes using sensors	181	190	$41
94375	Test to measure rate of airflow	545	821	$27
94618	Test for exercise-induced lung stress	229	262	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	1,084	40,560	$855,408
Breo Ellipta	Fluticasone/Vilanterol	542	21,628	$281,392
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	163	5,940	$122,207
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	135	4,770	$73,301
Eliquis	Apixaban	85	3,030	$58,668

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	37	$37,733
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	56	390	$35,399
A7030	Full face mask used with positive airway pressure device, each	N	99	208	$21,321
A7031	Face mask interface, replacement for full face mask, each	N	78	184	$18,615
E0601	Continuous positive airway pressure (cpap) device	Y	55	341	$12,863

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$119	Itamar Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Philip James Abraham, M.D.?

Tedicare shows public-source Medicare data for Philip James Abraham, M.D. (NPI 1548375629), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip James Abraham, M.D. have ACO affiliation data?

Philip James Abraham, M.D. is shown with ACO affiliation data for Springfield Clinic ACO, LLC (MSSP, ACO ID A2587), IRCCO (MSSP, ACO ID A2619), and SSM IL ACO, LLC (MSSP, ACO ID A4832).

What billing organization is linked to Philip James Abraham, M.D.?

Philip James Abraham, M.D. is linked to SPRINGFIELD CLINIC, LLP (billing NPI 1780638478) in the available physician profile data.

Does Philip James Abraham, M.D. have Open Payments data?

Philip James Abraham, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.